326 related articles for article (PubMed ID: 28930233)
1. Dietary Isoflavones and Breast Cancer Risk.
Ziaei S; Halaby R
Medicines (Basel); 2017 Apr; 4(2):. PubMed ID: 28930233
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells.
Maggiolini M; Bonofiglio D; Marsico S; Panno ML; Cenni B; Picard D; Andò S
Mol Pharmacol; 2001 Sep; 60(3):595-602. PubMed ID: 11502892
[TBL] [Abstract][Full Text] [Related]
3. [Soy isoflavones--a therapy for menopausal symptoms?].
Wolters M; Hahn A
Wien Med Wochenschr; 2004 Jul; 154(13-14):334-41. PubMed ID: 15368955
[TBL] [Abstract][Full Text] [Related]
4. Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice.
Liu Y; Hilakivi-Clarke L; Zhang Y; Wang X; Pan YX; Xuan J; Fleck SC; Doerge DR; Helferich WG
Mol Nutr Food Res; 2015 Aug; 59(8):1419-30. PubMed ID: 25820259
[TBL] [Abstract][Full Text] [Related]
5. Soy isoflavones as safe functional ingredients.
Song WO; Chun OK; Hwang I; Shin HS; Kim BG; Kim KS; Lee SY; Shin D; Lee SG
J Med Food; 2007 Dec; 10(4):571-80. PubMed ID: 18158825
[TBL] [Abstract][Full Text] [Related]
6. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast.
Wood CE; Register TC; Franke AA; Anthony MS; Cline JM
Cancer Res; 2006 Jan; 66(2):1241-9. PubMed ID: 16424064
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
[TBL] [Abstract][Full Text] [Related]
8. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
9. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast.
Hargreaves DF; Potten CS; Harding C; Shaw LE; Morton MS; Roberts SA; Howell A; Bundred NJ
J Clin Endocrinol Metab; 1999 Nov; 84(11):4017-24. PubMed ID: 10566643
[TBL] [Abstract][Full Text] [Related]
10. Potential risks and benefits of phytoestrogen-rich diets.
Cassidy A
Int J Vitam Nutr Res; 2003 Mar; 73(2):120-6. PubMed ID: 12747219
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones: are they useful in menopause?
Vincent A; Fitzpatrick LA
Mayo Clin Proc; 2000 Nov; 75(11):1174-84. PubMed ID: 11075748
[TBL] [Abstract][Full Text] [Related]
12. Interactions of isoflavones and other plant derived estrogens with estrogen receptors for prevention and treatment of breast cancer-considerations concerning related efficacy and safety.
Leclercq G; Jacquot Y
J Steroid Biochem Mol Biol; 2014 Jan; 139():237-44. PubMed ID: 23274118
[TBL] [Abstract][Full Text] [Related]
13. A model to estimate the oestrogen receptor mediated effects from exposure to soy isoflavones in food.
Safford B; Dickens A; Halleron N; Briggs D; Carthew P; Baker V
Regul Toxicol Pharmacol; 2003 Oct; 38(2):196-209. PubMed ID: 14550760
[TBL] [Abstract][Full Text] [Related]
14. Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studies.
Kwon Y
Food Sci Nutr; 2014 Nov; 2(6):613-22. PubMed ID: 25493176
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture.
Zava DT; Blen M; Duwe G
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):637-45. PubMed ID: 9168008
[TBL] [Abstract][Full Text] [Related]
16. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
17. Lack of estrogenic or antiestrogenic actions of soy isoflavones in an avian model: the Japanese quail.
Wilhelms KW; Scanes CG; Anderson LL
Poult Sci; 2006 Nov; 85(11):1885-9. PubMed ID: 17032818
[TBL] [Abstract][Full Text] [Related]
18. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.
Levis S; Strickman-Stein N; Doerge DR; Krischer J
Contemp Clin Trials; 2010 Jul; 31(4):293-302. PubMed ID: 20230914
[TBL] [Abstract][Full Text] [Related]
19. Association of soy and fiber consumption with the risk of endometrial cancer.
Goodman MT; Wilkens LR; Hankin JH; Lyu LC; Wu AH; Kolonel LN
Am J Epidemiol; 1997 Aug; 146(4):294-306. PubMed ID: 9270408
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of endocrine-disrupting substances: phytoestrogens.
Lephart ED; Setchell KD; Handa RJ; Lund TD
ILAR J; 2004; 45(4):443-54. PubMed ID: 15454683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
